Bayer, Germany's largest drugmaker, is among the suitors vying for animal health businesses that are coming to market as a result of antitrust concerns about mergers among U.S. drug majors, Financial Times Deutschland (FTD) reported.
According to a Reuters report, FTD cited financial market sources and people at Bayer's animal health unit.
A Bayer spokesman declined to comment when contacted by Reuters.
Bayer's management told analysts at a meeting last month that its animal health division was among the businesses that could benefit from acquisitions.
Bayer in Talks to Buy Animal Drugs Business-paper
GERMANY - Bayer is in advanced takeover talks to expand its animal health unit and is likely to benefit from the ongoing overhaul of the U.S. healthcare sector, a German newspaper said.
